Recent 8-K filings for GPAT
Highest-materiality recent filing
GP-Act III extends deal deadline to Nov 2026; $215M redeemed from trust
- Shareholders approved extension of business combination deadline from May 13 to Nov 13, 2026.
- 19,776,272 Class A shares redeemed at ~$10.89/share, aggregate ~$215.4M, trust falls to ~$97.8M.
-
GP-Act III extends deal deadline to Nov 2026; $215M redeemed from trust
Shareholders approved extension of business combination deadline from May 13 to Nov 13, 2026.
-
GP-Act III enters non-redemption deals covering 8.07M shares to extend SPAC deadline to Nov 2026
Non-Redemption Agreements with investors covering 8,074,387 Class A ordinary shares to vote for extension.
-
GP-Act III SPAC extends business combination deadline to Nov 13, 2026 via non-redemption agreements
Enters non-redemption agreements with shareholders to support extension of deadline from May 13 to Nov 13, 2026.
-
Adjournment proposal approved: 21,424,593 for, 8,064,137 against, 1,000 abstentions (82.06% quorum).
-
GP-Act III Acquisition eliminates dual-class structure; all 7.2M Founder Shares converted to Class A
Sponsor HoldCo and three independent directors converted all 7,187,500 Class B shares into Class A shares on a one-for-one basis.
-
Adjournment proposal passed with 21.3M For, 8.0M Against, 1K abstentions; quorum 81.67% of 35.9M shares.
-
GP-Act III Acquisition Corp. announces separate trading of shares and warrants starting July 1, 2024
Holders of 28.75M units sold in IPO (May 13, 2024) may separate into Class A shares and warrants from July 1, 2024.
-
GP-Act III Acquisition Corp. completes $287.5M IPO and $7M private placement
Sold 28,750,000 units at $10.00 each, including full over-allotment, raising $287.5M.
-
Closed IPO of 28,750,000 units at $10.00/unit, gross proceeds of $287.5M.
Materiality & sentiment trend
Max materiality 0.75 · Median 0.55 · Most common event other_material